Complex and risky technologies--technologies such as new drugs for the treatment of AIDS that promise great benefits to our society but carry significant risks--pose many problems for political leaders and the policy makers responsible for overseeing them. Public agencies such as the Food and Drug Administration are told by political superiors not to inhibit important technological advances and may even be charged with promoting such development but must also make sure that no major accidents occur under their watch. Given the large costs associated with catastrophic accidents, the general public and elected officials often demand reliable or failure-free management of these technologies and have little tolerance for the error.
Research in this area has lead to a schism between those who argue that it is possible to have reliable management techniques and safely manage complex technologies and others who contend that such control is difficult at best. In this book C. F. Larry Heimann advances an important solution to this problem by developing a general theory of organizational reliability and agency decision making. The book looks at both external and internal influences on reliability in agency decision making. It then tests theoretical propositions developed in a comparative case study of two agencies involved with the handling of risky technologies: NASA and the manned space flight program and the FDA's handling of pharmaceuticals--particularly new AIDS therapies.
Drawing on concepts from engineering, organizational theory, political science, and decision theory, this book will be of interest to those interested in science and technology policy, bureaucratic management and reform, as well as those interested in health and space policy.
C. F. Larry Heimann is Assistant Professor of Political Science, Michigan State University.
"synopsis" may belong to another edition of this title.
C. F. Larry Heimann is Assistant Professor of Political Science, Michigan State University.
"About this title" may belong to another edition of this title.
Seller: AwesomeBooks, Wallingford, United Kingdom
hardcover. Condition: Very Good. Acceptable Risks: Politics, Policy and Risky Technologies This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. . Seller Inventory # 7719-9780472108138
Quantity: 1 available
Seller: INDOO, Avenel, NJ, U.S.A.
Condition: New. Brand New. Seller Inventory # 9780472108138
Seller: Bahamut Media, Reading, United Kingdom
hardcover. Condition: Very Good. This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. Seller Inventory # 6545-9780472108138
Quantity: 2 available
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # FW-9780472108138
Quantity: 2 available
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Hardback. Condition: New. Complex and risky technologies--technologies such as new drugs for the treatment of AIDS that promise great benefits to our society but carry significant risks--pose many problems for political leaders and the policy makers responsible for overseeing them. Public agencies such as the Food and Drug Administration are told by political superiors not to inhibit important technological advances and may even be charged with promoting such development but must also make sure that no major accidents occur under their watch. Given the large costs associated with catastrophic accidents, the general public and elected officials often demand reliable or failure-free management of these technologies and have little tolerance for the error. Research in this area has lead to a schism between those who argue that it is possible to have reliable management techniques and safely manage complex technologies and others who contend that such control is difficult at best. In this book C. F. Larry Heimann advances an important solution to this problem by developing a general theory of organizational reliability and agency decision making. The book looks at both external and internal influences on reliability in agency decision making. It then tests theoretical propositions developed in a comparative case study of two agencies involved with the handling of risky technologies: NASA and the manned space flight program and the FDA's handling of pharmaceuticals--particularly new AIDS therapies. Drawing on concepts from engineering, organizational theory, political science, and decision theory, this book will be of interest to those interested in science and technology policy, bureaucratic management and reform, as well as those interested in health and space policy. C. F. Larry Heimann is Assistant Professor of Political Science, Michigan State University. Seller Inventory # LU-9780472108138
Quantity: 1 available
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. The control of the use of beneficial but potentially dangerous technologies by the FDA and NASA Num Pages: 208 pages, 26figs.2tabs. BIC Classification: KN. Category: (P) Professional & Vocational. Dimension: 230 x 160 x 23. Weight in Grams: 545. . 1998. Hardcover. . . . . Seller Inventory # V9780472108138
Quantity: 1 available
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 188 pages. 9.50x6.50x1.00 inches. In Stock. Seller Inventory # __0472108131
Quantity: 2 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Hardback. Condition: New. New copy - Usually dispatched within 4 working days. Seller Inventory # B9780472108138
Quantity: 2 available
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. The control of the use of beneficial but potentially dangerous technologies by the FDA and NASA Num Pages: 208 pages, 26figs.2tabs. BIC Classification: KN. Category: (P) Professional & Vocational. Dimension: 230 x 160 x 23. Weight in Grams: 545. . 1998. Hardcover. . . . . Books ship from the US and Ireland. Seller Inventory # V9780472108138
Seller: Rarewaves.com UK, London, United Kingdom
Hardback. Condition: New. Complex and risky technologies--technologies such as new drugs for the treatment of AIDS that promise great benefits to our society but carry significant risks--pose many problems for political leaders and the policy makers responsible for overseeing them. Public agencies such as the Food and Drug Administration are told by political superiors not to inhibit important technological advances and may even be charged with promoting such development but must also make sure that no major accidents occur under their watch. Given the large costs associated with catastrophic accidents, the general public and elected officials often demand reliable or failure-free management of these technologies and have little tolerance for the error. Research in this area has lead to a schism between those who argue that it is possible to have reliable management techniques and safely manage complex technologies and others who contend that such control is difficult at best. In this book C. F. Larry Heimann advances an important solution to this problem by developing a general theory of organizational reliability and agency decision making. The book looks at both external and internal influences on reliability in agency decision making. It then tests theoretical propositions developed in a comparative case study of two agencies involved with the handling of risky technologies: NASA and the manned space flight program and the FDA's handling of pharmaceuticals--particularly new AIDS therapies. Drawing on concepts from engineering, organizational theory, political science, and decision theory, this book will be of interest to those interested in science and technology policy, bureaucratic management and reform, as well as those interested in health and space policy. C. F. Larry Heimann is Assistant Professor of Political Science, Michigan State University. Seller Inventory # LU-9780472108138
Quantity: 1 available